Project Grant H79TI088987
Award Date 9/30/26
Completion Date 9/29/31
Dollars Obligated $525K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded MC Dermott Center Inc., doing business as Haymarket Center, $525,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490). Haymarket Center will deliver comprehensive, integrated behavioral health and primary care services to 119 pregnant and postpartum women with substance use disorders and their 48...
- The Substance Abuse and Mental Health Services Administration awarded Family Ark, Inc. $524,432 on September 30, 2026, to expand family-centered substance use disorder treatment for pregnant, postpartum, and parenting women in southern Indiana under the Center for Substance Abuse Treatment Projects of Regional and National Significance program. Family Ark will implement ASAM Level 3.5 clinically managed high-intensity residential treatment integrated with existing outpatient, intensive...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the South Carolina Department of Alcohol & Other Drug Abuse Services $1,080,000 for the South Carolina Pilot Program for Treatment of Perinatal Substance Use Disorders on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490). The recipient, in collaboration with the Medical University of South Carolina,...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) awarded Aware Inc. $525,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to establish and operate a residential treatment program for pregnant and postpartum women with substance use disorder in rural western Montana. Aware Inc., a CARF-accredited, Medicaid-enrolled Montana nonprofit, is...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $96.037 million to the Maryland Department of Health Behavioral Health Administration on October 1, 2025, under the Block Grants for Prevention and Treatment of Substance Abuse (CFDA 93.959), a block grant program supporting state-level substance use prevention, treatment, and recovery services. The award funds prevention and treatment activities addressing alcohol and drug abuse, with...
- The Substance Abuse and Mental Health Services Administration awarded US Helping Us-People Into Living, Inc. three million dollars on September 30, 2025, under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) to implement HEPC FREE: Corridor of Care, a three-year hepatitis C elimination initiative targeting unsheltered individuals and those with substance use disorders, serious mental illness, or co-occurring conditions....
- SAMHSA awarded the Missouri Department of Mental Health $1.08 million on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to expand access to recovery housing, integrated evidence-based substance use disorder and maternal health services, and family supports for pregnant and postpartum women in Missouri. The recipient will operate the State Pilot Program for Treatment for Pregnant and Postpartum Women...
- The National Institute on Drug Abuse awarded Johns Hopkins University $198,164 on October 17, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research examining barriers to medications for opioid use disorder (MOUD) treatment for individuals transitioning from correctional facilities to community settings. The research employs a complex systems approach combining quantitative and qualitative methods. Specific aims include examining the structure and function...
- The National Institute on Drug Abuse awarded Hennepin Healthcare Research Institute $193,320 on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support development of a mentored career development award (K01) focused on improving behavioral healthcare for mothers with opioid use disorder, their children, and families. The award funds a five-year research initiative through June 30, 2031, based in Minneapolis, Minnesota. The investigator will develop a strategy...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded Cope Community Services, Inc. $1.499 million on September 30, 2026, under the Assisted Outpatient Treatment program (CFDA 93.997) to implement the COPE ANCHOR program, a five-year assisted outpatient treatment initiative serving 350 adults with serious mental illness in Pima County, Arizona. ANCHOR expands access to court-ordered outpatient treatment through coordinated case management, clinical services, and...